James Madison University

JMU Scholarly Commons
Doctor of Nursing Practice (DNP) Final Clinical
Projects

The Graduate School

Fall 2019

The effect of implementing symptom feedback into psychiatric
care at a non-profit clinic
Deirdre Rea

Follow this and additional works at: https://commons.lib.jmu.edu/dnp201019
Part of the Nursing Commons, and the Other Social and Behavioral Sciences Commons

Recommended Citation
Rea, Deirdre, "The effect of implementing symptom feedback into psychiatric care at a non-profit clinic"
(2019). Doctor of Nursing Practice (DNP) Final Clinical Projects. 29.
https://commons.lib.jmu.edu/dnp201019/29

This Dissertation is brought to you for free and open access by the The Graduate School at JMU Scholarly
Commons. It has been accepted for inclusion in Doctor of Nursing Practice (DNP) Final Clinical Projects by an
authorized administrator of JMU Scholarly Commons. For more information, please contact dc_admin@jmu.edu.

The Effect of Implementing Symptom Feedback into Psychiatric
Care at a Non-Profit Clinic

Deirdre O. Rea

A Clinical Research Project submitted to the Graduate Faculty of

James Madison University

In

Partial Fulfillment of the Requirements
for the degree of
Doctor of Nursing Practice

School of Nursing

December 2019

FACULTY COMMITTEE
Committee Chair: Jeannie Scruggs Garber
Committee Member:
Bridgette Vest

Table of Contents
Table of Contents ..............................................................................................................ii
List of Tables ...................................................................................................................iv
List of Figures ...................................................................................................................v
Abstract ............................................................................................................................vi
Introduction.......................................................................................................................1
Background .......................................................................................................................2
Literature Review..................................................................................................2
The Value of MBC.......................................................................................4
The Barriers to MBC....................................................................................5
The Need for MBC ......................................................................................7
Aim/Purpose..........................................................................................................8
Objectives..............................................................................................................8
Theoretical Framework .........................................................................................9

Methods...........................................................................................................................10
Project Study Design...........................................................................................10
Context ................................................................................................................10
Sample.................................................................................................................12
Quantitative Procedure........................................................................................12
Measures .............................................................................................................13
Qualitative Procedure..........................................................................................14
Qualitative Questions ..........................................................................................15
Analysis...............................................................................................................16
Project Timeline ..................................................................................................17
Ethical Considerations ........................................................................................18

Results .............................................................................................................................19
Quantitative Results ............................................................................................19
ii

Content Analysis of Interview Responses ..........................................................27
Project Process Results ……………………………………………………….. 40

Discussion .......................................................................................................................42
Limitations ..........................................................................................................45
Implications for Practice .....................................................................................46
Conclusion ......................................................................................................................47

Appendices......................................................................................................................49
Patient Health Questionnaire-9 ...........................................................................49
Generalized Anxiety Disorder-7 .........................................................................50
Consent Form ......................................................................................................51

References .......................................................................................................................54

iii

List of Tables
Table 1

Paired samples t-test for PHQ-9 scores .........................................................20

Table 2

Paired samples t-test for GAD-7 scores.........................................................21

Table 3

Descriptive statistics on GAD-7 ANOVA measurements .............................22

Table 4

Pairwise comparisons of TP1, TP2, and TP3 GAD-7 measurements ...........22

Table 5

Mauchlys’s Test of Sphericity on PHQ-9 data ..............................................23

Table 6

Greenhouse-Geisser correction for sphericity ...............................................24

Table 7

Test of Between-Subjects Effects for gender on PHQ-9 data .......................24

Table 8

Estimated Marginal Means of gender over time............................................25

Table 9

Pairwise comparison of PHQ-9 scores for female gender over time.............25

Table 10

Means, standard deviations & frequency distribution of qualitative codes ..39

iv

List of Figures
Figure 1

Project Timeline ...........................................................................................16

Figure 2

Graphed means of male (1.0) and female (2.0) scores on PHQ-9................26

Figure 3

Code map 1 of qualitative interview data.....................................................38

Figure 4

Code map 2 of qualitative interview data .....................................................38

v

Abstract
Background: Healthcare is moving toward a value-based system with
reimbursement based on performance. Charitable organizations providing health services
need to demonstrate positive outcomes for continued grant funding. Measurement-Based
Care (MBC) is evidence-based, can improve patient outcomes and objectively document
success. Studies show most psychiatric providers do not utilize MBC in their own
practices citing lack of time, and a belief that their clinical judgment supersedes a
measurement tool. The purpose of the study was to establish the use of patient-reported
symptom measurement tools in a non-profit psychiatric clinic and determine if an officebased strategy to proactively and regularly report to providers their patient’s scores
affected treatment outcomes and overall adoption of MBC.
Methods: The study entailed an explanatory mixed methods design with a pre-test/posttest quantitative measurement and a semi-structured qualitative interview with providers
following data collection. Office staff facilitated completion and electronic medical
record entry of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety
Disorder-7 (GAD-7) patient self-report measurement tools for depression and anxiety on
each patient at every visit. Trended scores were proactively reported to providers prior to
the visit during months 3 through 6. Score comparisons were made prior to and after the
reporting period. Qualitative questions explored usefulness of MBC and the effectiveness
of proactive reporting.
Results: Dependent t-tests measured differences in the means at three measurement
points. A repeated measures ANOVA tested the effects of client gender, provider
discipline and treatment modality on scores. Qualitative data was recorded, transcribed,
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and coded for thematic pattern identification. Results showed significant reduction on
scores for both depression and anxiety over the full measurement period with statistically
significant decreases in anxiety scores during the intervention period. A between-factors
response was found for gender. Qualitative responses showed younger providers more
likely to use MBC to guide treatment decisions. MBC was viewed as having utility as an
adjunct. All recommended continued office facilitation but wanted control over choice of
tool and to see scores in real time.
Conclusion: An office process that assists with routine collection of patient data,
consistently reporting it to providers, can facilitate adoption of MBC to guide treatment
decisions and produce evidence of positive outcomes. Successful change may be obtained
with a team approach to the removal of barriers.
Key words: Measurement-Based Care, outcome monitoring, behavioral health,
psychiatry
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Introduction
The use of measurement-based care (MBC) as a mechanism to monitor clinical
outcomes extends back to Florence Nightingale and is well established as an evidencebased practice (Chun and Bafford, 2014). In late 2016, the Joint Commission published
new standards relating to the use of MBC in behavioral health as it is now considered
best practice. The new standards mandate evidence of active use of the measurement
results in informing care and driving treatment (Lavin, Berry & Williams, 2017). The
standard went into effect January 1, 2018.
Incorporating evidence-based practice into care can be difficult and require
creative and targeted change management approaches. This is the foundation of
implementation science which looks to analyze and define what works, for whom and
under what circumstances to promote the uptake of scientific knowledge into front line
practice (Eccles & Mittman, 2006). Factors that impact success include the characteristics
of the intervention and their complexity and adaptability, the cost, the stakeholders
involved and the context where it is carried out -which can present its own set of barriers
and facilitators (Global Alliance for Chronic Diseases [GACD], n.d.).
There are many indirect stakeholders affected by the success of the incorporation
of MBC into care in any organization. But the most direct stakeholders include the
patients completing the measurements and the providers seeing and acting on the results.
Making sure these actually happen are the primary challenges.
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Background
In 2001, the Institute of Medicine introduced the six, healthcare improvement
aims that summoned the field to provide evidence of its effectiveness in managing
population health (IOM, 2001). The Affordable Care Act offered payment incentives for
the documentation of clinical success in a move away from care based on volume toward
that of value (Kocher, 2010). Over the last 20 years, the literature has established that
Measurement-Based Care (MBC) is an evidence-based practice that can demonstrate and
significantly improve patient outcomes (Fortney, 2016; The Kennedy Forum, 2015).
While many providers state that they agree, studies show that most do not utilize MBC in
their own practices citing lack of time, and a belief that their clinical judgment supersedes
a measurement tool (Jensen-Doss, 2018). Using Lippitt’s Nursing Theory of Change and
Lewin’s Force-field analysis framework of driving and restraining forces (Mitchell,
2013), this study instituted and measured MBC use and scores both before and after an
office-based intervention strategy to regularly disseminate to patients and expose
providers to the sequential scores on the PHQ-9 and GAD-7 of their patients in the outpatient psychiatric practice of a non-profit, volunteer, charitable clinic.
Literature Review
Databases from MEDLINE, CINAHL, PsycINFO and Google Scholar were
searched using the keywords Measurement-Based Care and Outcome Monitoring
combined with the terms Psychiatry, Behavioral Health, Anxiety, and Depression in order
to limit findings to mental health related articles. The search included peer reviewed
articles written in English between the years 2000 and 2019. Exceptions to this were the
articles on the psychometrics of the measurement tools substantiating their reliability and

3

validity. The wide span in years was used to capture the range of experiences and issues
related to establishing measurement-based care in behavioral health.
The Institute of Medicine’s (IOM) release of To Err is Human: Building a Safer
Health System (Kohn, 1999) brought to the fore the problems with patient safety and
quality in healthcare in the United States. This was followed by Crossing the Quality
Chasm: A New Health System for the 21st Century (Committee on Quality of Healthcare
in America, 2001) which further illuminated the qualitative and quantitative divide
between what was established as good healthcare and what people were actually
receiving. The report laid the foundation for change with the identification of six aims for
improvement. Healthcare should be safe with safety as a property of the healthcare
system as a whole. It should be effective without overuse or underuse of best available
treatments. It should be patient-centered with the patient playing an active role in their
care. It should be timely with prompt attention paid to changes in condition. It should be
efficient such that it reduces waste in time and cost in maximizing health. And it should
be equitable for all populations regardless of race, creed, gender and culture. At its core,
these aims directed a theoretical shift to care based on quality and value rather than
volume but created a dilemma in determining progress toward that goal.
Porter, Larsson and Lee (2016) cite evidence from other fields suggesting that
systematic outcome measurement can be used as a basis for determining performance and
value improvement. To that end, the National Strategy for Quality Improvement in
Healthcare, now the National Quality Strategy (NQS), was developed in 2011 with a
collaboration of over 300 stakeholders in the healthcare arena. Led by the Agency for
Healthcare Quality and Research (AHRQ) on behalf of the Department of Health and
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Human Services (HHS), the strategy focuses on clinical quality measures used to reach
the IOM’s six aims for improvement and the Institute for Healthcare Improvement’s
Triple Aim of improving the experience of care, the health of the population and the per
capita cost of care (Berwick, 2008). Within this group, the HHS Measurement Policy
Council was created and met in 2012 to align the identified clinical measures across all of
the HHS federal programs and to support private sector adoption of the core measures as
a standard for healthcare (AHRQ, 2017). This, in combination with the passing of the
2009 Affordable Care Act, with its move toward reimbursement based on performance,
made it imperative to be able to show positive outcomes (Kocher, 2010). The Council,
along with the International Consortium for Health Outcomes Measurement (ICHOM),
has since, using randomized, controlled trials (RCTs), established validated, evidencebased measures, including patient-reported measurement tools, for nine health conditions
including depression (AHRQ, 2017; Porter, 2016).
The value of measurement-based care.
Fortney, et al. (2016), however, noted the discrepancy between the outcomes
obtained from RCTs and those in routine care. The better outcomes from RCTs were
directly tied to treatment protocols that included regular, systematic measurement of
symptom acuity followed by evidence-based treatment adjustments to correct poor
response – the foundational tenets of measurement-based care (MBC). Harding, Rush
and Arbuckle (2011) define MBC as “enhanced precision and consistency in disease
assessment, tracking, and treatment to achieve optimal outcomes” (p. 1137). Fortney, et
al. (2016), further break it down to “the systematic administration of symptom rating
scales and use of the results to drive clinical decision making at the level of the individual
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patient” (p.1). Scales are not intended to substitute for clinical perception and judgment
but rather to augment symptom assessment to improve the identification of those patients
not responding to their current treatment regimen. The Kennedy Forum (2015) and
Valenstein, et al. (2009) assert that the objective results validate the rationale for
adjustments in treatment for both medication and psychotherapy-based interventions.
However, a one-time screening for the presence of a disorder lacks effectiveness in
monitoring treatment response. It is argued that screening must be done frequently for
timely feedback and clinically actionable interventions to be initiated (Bickman, 2011;
Gilbody, 2008; Hatfield, D., 2009; Priebe, 2002). Bickman (2011), Lambert, et al. (2003)
and Reese, et al. (2009) recommend screening at each visit, using the patient-reported
responses to increase patient involvement in care, monitor for deterioration in treatmentresistant patients and inform clinical decisions.
The barriers to measurement-based care.
Despite compelling evidence for the efficacy of measurement-based care and its
importance in showing outcomes, data suggests it is rarely used in every day clinical
settings (Jensen-Doss, 2018; Trivedi, 2007; Zubkoff, et al., 2012). The reasons for this
are multiple including: the belief that clinical judgment and experience supersede the use,
reliability and validity of a tool (Dowrick, 2009; Hatfield, 2009); the belief that the scales
take too much time, especially with a lack of office resources (Kotte, et al., 2016;
Meehan, 2006; Zimmerman, 2008); concerns over lack of training on the tools (Batty, et
al., 2013; Scott, 2015; Zubkoff, 2012); concerns over patient perceptions of and
willingness to complete the tools along with provider concern over the red uction of the
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human element of care (Dowrick, 2009; Kotte, 2016); and skepticism over the political
and economic motives for the use of the tools and their results (Meehan, 2006).
But other studies have refuted these objections. The reliability and validity of
most tools were well studied and founded (Beard, 2016; Guo,2017; Kroenke, 2001).
Porter (2016) reports that Information Technology has responded with software solutions
that can automate data collection through embedded tools in the EMR, thus streamlining
the data gathering, aggregation and bench marking of outcomes. At least two studies
(Trivedi, 2006; Rush, 2006) found patient ratings on depression screenings were
equivalent to clinician-rated screening results. Dowrick (2009) found that patients
embraced the questionnaires viewing them as an indication that the providers were taking
their problems seriously by requesting their feedback. The economic motives have
largely been clarified as the shift toward reimbursement for value-based care and need for
showing positive outcomes (Fortney, 2016). Duffy, et al., (2008) strongly assert that
integration of MBC into routine practice is feasible “even in practices with limited
resources” (p. 1148).
Recent studies have begun to explore ways to address clinician barriers to the use
of MBC. Jenson-Doss (2018) found a strong link between attitudes and use. Attitudes
varied based on age and years of experience with younger providers more open to the use
of the measurement tools. Use was higher in settings with resources to support
assessment or with organizational requirements to monitor progress for financial
reporting. Additionally, the more providers used the symptom tracking tools, the more
value they found in their clinical use. In an integrated primary care- mental health clinic,
Zubkoff established that providers rarely accessed the results of patient-reported
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measurements that were part of routine data collection with the clinic. But when provided
current reports of their patient’s results, the clinician’s found the format very useful and
highly recommended continuing the process. Zubkoff attested that, “Providers who had
not been exposed to measurement-based care perceived it to be unhelpful, whereas the
same providers found it highly valuable after brief exposure to it” (p. 92). No other
intervention was used other than exposure to the patient’s self-reported measurements on
the tools. This suggests the important role of a supportive environment in increasing
adoption of new initiatives. Evaluating the logistics of the office and formatting the
workflow to include routine collection and reporting of measurement responses can result
in successful implementation of MBC strategies.
The need for measurement-based care.
In the United States, mental health disorders are the basis for 27% of all
disabilities while only 6.8% of government healthcare spending is directed to psychiatric
treatment (Vos, et al., 2012; Melek, et al., 2014). Mental health care is historically
underfunded and may be related to the difficulty in demonstrating to payors the value of
treatment. Without observable results, payors may perceive mental health treatment as
having a poor return on investment compared with other medical services. Non-profit,
501c3, charitable organizations providing mental health services are not immune from
this trend. Glennon, Hannibal and Meehan (2017) report how even charities are being
held to higher accountability standards. Stiff competition for dwindling funds is driving
the need to show positive outcomes for grant funders to justify continued financial
support of an agency. Funders want the greatest return on their investment of donated
dollars (Mitchell, 2016). Without this financial support, the long-term sustainability of
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these agencies is threatened impacting the underserved population who are the
beneficiaries of their services. It is in all these areas where measurement-based care can
meet these needs. According to Scott (2015), regular use of MBC provides evaluative
metrics for an organization to serve as an indicator for overall performance which can be
compared against benchmarks and goals to substantiate a positive return on investment.
Aim/Purpose
The purpose of the study was to establish the use of patient-reported symptom
measurement tools in a non-profit psychiatric clinic and determine if an office-based
strategy to proactively and regularly report to providers their patient’s scores affected
treatment outcomes as reflected in both score results over time and through a semistructured interview on provider perceptions on the impact of the reports on treatment
planning.
Objectives
1. To institute the regular practice of obtaining measurements of patient-reported
symptom scores on the PHQ-9 and GAD-7 of all patients seen at the clinic for
either medication management or psychotherapy and embed in the new EMR.
Goal: 90% completion rate.
2.

To measure and compare scores on the PHQ-9 and GAD-7 both prior to and
following an office-based intervention to provide intentional, proactive reporting
of patient scores to providers. Goal: 10% change toward positive.

3. To determine the effect on providers of intentional, proactive reporting of their
patient scores toward assessment and treatment decisions.
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Theoretical Frameworks
Two frameworks were identified for this project. The first was Ronald Lippitt’s
Theory of Change in Nursing which is an expanded version of Lewin’s (1951) three-step
process involving seven steps that move in line with the nursing assessment process
(Mitchell, 2013). It is predicated on bringing in an external change agent to put a change
initiative in place (How to Apply, 2018). The first three phases fall under the nursing
category of Assessment. The first phase is diagnosing the problem and developing a
guideline for the proposed change. The second phase is assessing motivation and capacity
for change and includes the driving and restraining forces from Lewin’s (1951) Forcefield analysis. Phase three is assessing the change agent’s motivation and resources.
Under Planning comes phase four with the identification of the change objective, the final
draft of the plan and the timeline and phase five which focuses on choosing a role for the
change agent. Change agents are active parts of the process, managing staff and
supporting the initiative. Under Implementation is phase six where the change is
maintained with emphasis on communication and feedback. Evaluation encompasses
phase seven which involves terminating the helping relationship and the withdrawal of
the change agent along with making the change permanent through policy development
(Mitchell, 2013).
The second framework was the Institute for Healthcare Improvement’s Model for
Improvement (Langley, 2009). The Model for Improvement includes making small-scale
changes using Plan-Do-Study-Act (PDSA) cycles. Each step of the project was
performed in a distinct cycle to coincide with the framework.
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Methods
Project Study Design
The study was a quality improvement, implementation initiative with an
exploratory, mixed methods design. It entailed a pre-test/post-test quantitative
measurement along with a semi-structured qualitative descriptive interview with
participants following the final data collection. The intervention involved (a) the
implementation of the standardized use of the Patient Health Questionnaire-9 (PHQ-9)
depression screening self-report tool and the Generalized Anxiety Disorder-7 (GAD-7)
anxiety screening self-report tool for all clients at each office visit, (b) facilitation and
management of this process by office staff, and (c) the proactive reporting of scores to
providers.
Context
The setting was a Psychiatric Clinic (Clinic) run under a non-profit community
agency in a small mid-Atlantic city. Volunteer psychiatric providers (Nurse Practitioners
[NP], Medical Doctors [MD], Doctors of Osteopathy [DO], third year psychiatric medical
residents, Clinical Psychologists [PhD], Physicians Assistants [PA], Social Workers
[SW], Registered Nurses [RN], and other psychiatric professionals) offered intake
assessments, medication management services, the medication, itself, and psychotherapy
to clients in a circumscribed geographic area that included two small cities and three
counties. Clients were required to be uninsured, have incomes below 200% of the federal
poverty level and be ineligible for services from a state agency due to the absence of
psychiatric hospitalizations within the prior two years. Clients received services onsite at
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the agency. Providers offered services either face-to-face or by teleconference. With one
provider exception, psychotherapy was provided weekly. Medication evaluation and
management visits generally occurred monthly with a few clients either bi-monthly or
quarterly. There were 53 active clients during the study period.
The organization maintained operations solely through the use of grant funding
and private donations. Applications to grant funders had included the services offered and
the number of clients served from the community but had never reported results or
outcomes as these had never been measured. Additionally, there was no ‘graduation
criteria’ in place to indicate that a client was stable and could be managed in a primary
care setting. This resulted in some clients having remained at the Clinic for years,
limiting the ability of the Clinic to reach a broader audience.
The decision to institute a new procedure for measurement-based care was made
by the Board of Directors of the organization as part of their strategic plan. The study
proposal was discussed and reviewed by the Executive Director (ED) and voted on by the
Board of Directors granting permission to proceed (See Ethics). The clinic was moving
from a paper-based charting system to an electronic medical record (EMR). The PI was
responsible for instituting the use of the EMR and developing the measurement-based
system. As a part of the project, the PI was named as the identified superuser for the
EMR computer program and given full access to its contents.
All providers were given an in-person, individual training session by the PI on the
use of the EMR for their clients. User ID’s and passwords were established. During
training, each provider was shown the screening section of the EMR where the
measurement tools were located and embedded and were informed that the Clinic would
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begin using the PHQ-9 and GAD-7 as outcome measures to determine Clinic
effectiveness. They were told that the scores would be available to see in the EMR.
Sample
The sample was a non-randomized convenience sample of psychiatric providers at
the Clinic. Inclusion criteria for the study were that (a) participants be English speaking;
(b) licensed, certified or in active training in psychiatric advanced practice, (c) actively
seeing and following, as a provider, at least one client at the Clinic; and (d) have patient
encounters with Clinic clients at least once per month. Exclusion criteria included (a) any
Clinic volunteer staff who were not licensed or certified in psychiatric advanced practice,
(b) only provided the intake assessment encounter, or (c) were active with clients less that
a minimum of once per month. The psychiatric providers included in the study were:
third year psychiatric medical residents in an assigned psychotherapy-only rotation (N=
6, male (M)- 4, female (F)- 2); Licensed Psychotherapists (N=2, one Social Worker and
one Clinical Psychologist; M- 0, F- 2); board certified psychiatric prescribers (N=6, one
female Psychiatric-Mental Health Nurse Practitioner, one female Physician’s Assistant, 2
DO’s, 2 MD’s; M- 2; F- 4) and one hybrid female fourth year psychiatric resident who
volunteered providing both psychotherapy and pharmacotherapy services. All residents
(N=7) had less than 5 years of experience in the field of Psychiatry while all other
participants (N= 8) had over 10 years in active practice in the psychiatric field.

Quantitative Procedure
Beginning in mid-November, 2018, (Cycle 1) all clients of the clinic were
required to complete a self-reported PHQ-9 and GAD-7 questionnaire on check-in at
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every visit. Paper questionnaires were distributed and collected by the office manager.
The investigator collected the questionnaires on a weekly basis and entered the scores
into the Screening section of each client’s electronic medical record. All scores were
available and visible to providers in the EMR. Individual scores were also maintained by
the investigator in Excel spreadsheets separated by provider and identified by the client’s
medical record number (MRN). Baseline scores were established for each client by late
December, 2018. The second measurement datapoint (Cycle 2) for evaluation of change
was obtained at the end of the ‘Care as Usual’ time period by capturing the last scores for
each patient prior to the start of the reporting intervention that began in mid -March, 2019.
Beginning on March 17, 2019 (Cycle 3), providers were sent an email from the PI
with their clients’ trended PHQ-9 and GAD-7 scores with the explanation that, as part of
the project, the PI would be sending these with updated information prior to each office
visit. Scores included the total tallied score on each tool from each office visit from mid November onwards for each client. Clients were identified by their MRN and emailed to
each provider on the Sunday prior to the client’s visit. Scores were randomly reported
either in Excel spreadsheet numbers, which included the dates of the office visits, or on a
trended graph generated by the EMR. This process was continued weekly for each client
and each provider from mid-March to Mid-June of 2019 when the final data
measurement of PHQ-9 and GAD-7 scores was obtained.
Measures
The clinical measurement tools used were the Patient Health Questionnaire-9
(Appendix I) and the Generalized Anxiety Disorder-7 (Appendix II) screening tools
approved for use by the Centers for Medicare and Medicaid Services as part of
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meaningful use standards. The PHQ-9 is a brief, self-administered, nine question,
psychometrically validated tool based on symptom criteria from the DSM-IV for Major
Depressive Disorder (Kroenke, 2001, Spitzer, 1999). Each question asks about specific
symptoms over the prior two weeks with answers on a 4-point scale rating from not at all
to several of the days to more than half the days and finally to nearly every day. Scoring
ranges from 0 to 3 points based on severity. The tool carries a sensitivity of 88%, a
specificity of 88% and a Cronbach’s alpha of 0.89 for determining a diagnosis of Major
Depression and measuring degree and changes in severity. Total tallied scores of 0-5, 5-9,
10-14, 15-19 and 20-27 were associated with none, mild, moderate, moderately severe
and severe depression, respectively. A score reduction of 5 points indicates a response, a
50% reduction in score is remission and a score less than 5 is stabilization (Katzelnick,
2011).
The GAD-7 is a brief, self-administered seven question, psychometrically
validated tool based on symptom criteria from the DSM-IV for Generalized Anxiety
Disorder. The tool has a structure similar to the PHQ-9 with a 4-point rating scale with
the same assessment distribution and an identical scoring system. The GAD-7 holds a
sensitivity of 89% and a specificity of 82% with a Cronbach’s alpha of 0.79-0.91
(Spitzer, 2006, Terrill, 2015, Williams, 2014).

Qualitative Procedure
An informational email was sent to all clinic providers to explain the purpose of
the study and requesting voluntary participation in a qualitative interview. Thirteen of the
15 providers were available and agreed to participate. Interviews took place following
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completion of quantitative data gathering in a four-week period from mid-June 2019
through mid-July, 2019 (Cycle 4).
Participants were asked to sign a consent form to allow both participation and
recording of the interviews with possible use of de-identified quotes (Appendix III). The
PI met individually with each participant and conducted semi-structured interviews
comprised of questions addressing attitudes, experiences and opinions on the use of
measurement-based care, in general, and the study process, in specific.
Qualitative Questions
1. Did you review the scores in the EMR prior to receiving the reports?
2. How often and how did you use the information from the tools?
3. What are your views on the usefulness of the information?
4. Did you change your treatment plan in any way based on the scores? If so, how?
5. What are your views of the usefulness of MBC outside of this clinic?
6. Would you recommend continued use of MBC?
Questions were reviewed by three psychiatric professionals to obtain agreement
on internal reliability.
All interviews were audio-recorded using Temi recording/transcribing software
on an iphone and lasted from 5 to 10 minutes in length. All participants were given a
$5.00 Starbucks gift card for their participation following the end of the interview.
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Analysis/Evaluation
Quantitative analysis was performed using the Statistical Package for the Social
Sciences (SPSS Version 26). Dependent t-tests were performed with SPSS to look for
differences in the means of the 3 comparisons – baseline (Timepoint [TP] 1) to midMarch (TP 2), TP 1 to mid-June (TP 3- final measurement) and TP 2 to TP 3 for both the
PHQ-9 and GAD-7 data. A linear, repeated measures ANOVA was utilized to test the
effect of client gender, (M,F), provider discipline (PMHNP, PA, DO, MD) and treatment
modality (medication only, medication and psychotherapy) on scores over time. Pairwise
comparisons were run for the effects of client gender, treatment modality and provider
discipline within the repeated measures.
For the qualitative analysis, transcripts of the recordings were reviewed against
the audio-files for clarity and correction by the PI and imported into HyperResearch
qualitative software. All transcripts were given a numeric identifier for differentiation.
The transcribed interviews were read and re-read with constant comparison of data points
between transcripts and against the overall interview. Codes were then generated to
describe the focus of the points or phrases. Three independent content experts, including
the investigator, coded the interview transcripts separately until no further codes could be
identified and saturation was determined to have been reached. Codes from the three
coders were synthesized and added to HyperResearch. Reports were generated on the
frequency and means of the codes and codes were placed in a Code Map according to
themes and sub-themes.
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Project Timeline

Dates
May, 2018

JuneSeptember,
2018

September.
2018

October 12,
2018
November,
2018

January,
2019
January 31,
2019

March 16,
2019

Planning
Pre-implementation
Meet with
Exec.
Director
and Board
of NonProfit to
obtain
approval
Education
sessions
for the PI
to become
a superuser for the
new EMR
Training sessions
with providers to
teach the use of new
EMR.
Go-live of new
EMR

Implementation Evaluation

Begin
administering
PHQ-9 and
GAD-7 to
clients
Submission
and approval
from IRB
1st datapoint
measurement
gathered for
baseline scores
of PHQ-9 and
GAD-7
2nd datapoint
measurement
of PHQ-9 and
GAD-7 scores;
Begin sending
reports to
providers
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June 15,
2019

June 16
through July
12, 2019
July through
September,
2019
September,
2019

Final datapoint
measurement
obtained of
PHQ-9 and
GAD-7 scores
Qualitative
interviews
performed

New process put
in place for
sustained practice
Data analysis

Report to Board
on findings and
recommendations

Figure 1. Project Timeline
Ethics
Ethical considerations included that the PI was on the Board of Directors for the
Non-Profit Organization. When proposing the study to the Board, the PI offered to step
down from the Board for the duration of the work so that there would not be a conflict of
interest or perceived pressure on the Board to agree to something with which they might
privately have concerns. The Board conferred privately with the Executive Director (ED)
and agreed that the work being proposed was in line with the strategic plan of the
organization for the Clinic and they saw no conflict. An institutional agreement was
already in place between the organization and JMU for use as a clinical site. There were
no ethical concerns about the study, itself, and it posed no risks beyond normal life for
either patients or providers. Costs incurred were covered by the PI and included time and
the cost for the gift cards.
Non-profit clinics often have no access to an Institutional Review Board (IRB) so
studies can rarely be conducted in these settings. As a student, the PI had access to the
IRB at James Madison University to review any ethical concerns. The study, protocol
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#19-0768, was approved by the James Madison University IRB in January, 2019.
Participants signed consent forms indicating their understanding of the purpose of the
study and agreeing to the recording and possible use of de-identified quotes prior to
participating in the qualitative interviews (Appendix III).
For security, all paper copies of the questionnaires were shredded after entry into
the EMR and Excel spreadsheet. The Excel spreadsheet data was kept on a password
protected computer at the PI’s residence only used for academics. No information was
placed in the Cloud. The data was deleted on completion of the project. For the
qualitative portion of the study, all recordings were erased following transcription.
Printed transcripts were maintained in a locked cabinet in a locked office for protection
during the analysis and shredded on completion of the study.
Results
Quantitative Results
A total of 15 providers met the criteria for inclusion in the study. The sample
included nine females (60%) and six males (40 %). Thirteen (87%) were native Englishspeaking Americans and three (13%) were foreign-born with English as a second
language. Six (40%) were third year medical residents in a Psychiatry residency program
and were providing psychotherapy services as part of a residency training rotation. One
(6%) was a 4th year resident volunteering to provide both psychotherapy and medication
management services. Two (13%) were licensed psychotherapists (1 Licensed Clinical
Social Worker and 1 Licensed Clinical Psychologist). Six (40%) were Board certified as
psychiatric specialists and provided medication management services only (1 PMHNPBC, 1 PA-SUP, 2 DO’s and 2 MD’s). All seven residents (46.7%) had less than five
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years of experience in the field of Psychiatry. The remaining eight licensed/certified
providers had a minimum of ten years in the field (53.3%). There were 44 active client
cases during the study timeframe included in the t-test results.
Prior to analysis, descriptive statistics were run on the PHQ-9 and GAD-7 data to
test for the assumption of normal distribution. Both sets of data satisfied the assumptions
for normality. The PHQ-9 skew was .172 and kurtosis level was 3.065. The GAD-7 skew
was -.874 and kurtosis level was .025. These are less than the maximum allowable values
for a t-test of skew < 2.0 and kurtosis < 9.0 as established by Posten (1984) indicating
that dependent samples t-tests were appropriate to conduct.
Paired two-tailed t-tests were used to compare the overall differences in the means
between the three measured time points (timepoint (TP) 1 [baseline], TP 2 and TP 3
[final]) on both the PHQ-9 and GAD-7 scores for all clients seen by the providers. For
the PHQ-9 scores there was a reduction in the means between each of the three time
periods (TP-1 to TP-2, TP-2 to TP-3 and TP-1 to TP-3) but no significant difference
found between TP-1 to TP-2 and TP-2 to TP-3. This suggests the intervention had no
effect on the PHQ-9 depression scores. The data does, however, show a significant
overall reduction in scores from TP-1 (M=1.043, SD= 4.796) to TP-3 (M=2.455, SD=
6.825); t (2.386), p< .022) indicating that the clinic’s providers were effective in reducing
symptoms of depression over the course of the 7 months of data extraction (Table 1.).
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Table 1.
Paired samples t-test for PHQ-9 scores
Paired Samples Test
Paired Differences
95% Confidence Interval

Mean
Pair

phq1 -

1

phq2

Pair

phq1 -

2

phq3

Pair

phq2 -

3

phq3

Std.

Std. Error

Deviation

Mean

of the Difference
Lower

Upper

Sig. (2t

df

tailed)

1.04255

4.79564

.69952

-.36550

2.45061 1.490

46

.143

2.45455

6.82490

1.02889

.37959

4.52951 2.386

43

.022

1.05128

7.24732

1.16050

-1.29803

3.40059

38

.371

.906

Paired two-tailed t-tests were then performed on the GAD-7 scores for the same
time periods. There was a more pronounced reduction in the score means between each
of the three time period comparisons. While there was little significance between the TP1 and TP-2 (M=1.208, SD= 5.347); t (1.566), p= .124) measurements, there was a
significant difference in the means during the intervention period from TP-2 to TP-3
(M=1.949, SD= 5.844; t (2.082), p< .044) as well as from the overall TP-1 to TP-3
measurements (M=2.910, SD= 5.242; t (3.681), p< .001). The results indicate that the
providers were effective in reducing anxiety symptoms during the entirety of the 7-month
time frame and that the intervention had a positive effect.
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Table 2.
Paired samples t-test for GAD-7 scores
Paired Samples Test
Paired Differences
95% Confidence Interval

Mean
Pair

gad1 -

1

gad2

Pair

gad1 -

2

gad3

Pair

gad2 -

3

gad3

Std.

Std. Error

Deviation

Mean

of the Difference
Lower

Upper

Sig. (2t

df

tailed)

1.20833

5.34733

.77182

-.34437

2.76104 1.566

47

.124

2.90909

5.24213

.79028

1.31534

4.50284 3.681

43

.001

1.94872

5.84424

.93583

.05423

3.84320 2.082

38

.044

A linear, mixed model, repeated measures ANOVA was then performed
separately on both the PHQ-9 and GAD-7 scores using time as the Within-Subjects
Factor and client gender (M, F), provider discipline (NP, PA, DO/MD) and treatment
modality (medication management alone, both medication management and
psychotherapy) as the Between Subjects Factors. The overall ‘N’ of active cases
included in the ANOVA was reduced to 39 as SPSS excluded all cases with missing
measurements.
For the GAD-7 data, descriptive statistics were run and data satisfied the
assumptions for Box’s Test of Equality of Covariance Matrices (p=.907), Levene’s Test
of Equality of Error Variances (p-values = .340 for TP1, .250 for TP2, .284 for TP3) and
Mauchley’s Test of Sphericity (p= .869). No main effects were found in the Between
Factors measurements, however, there was a significant difference in the main effect for
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time displayed in the pairwise comparisons from TP1 to TP3 (F= 6.067, partial eta
squared= .138; p < .003, CI .952-5.304) consistent with the t-test results.
Table 3.
Descriptive Statistics on GAD-7 ANOVA measurements
Descriptive Statistics
Mean

Std. Deviation

N

gad1

11.6667

5.67698

39

gad2

10.4872

6.17240

39

gad3

8.5385

5.81670

39

Table 4.
Pairwise comparisons of TP-1, TP-2 and TP-3 GAD-7 measurements
Pairwise Comparisons
Measure: MEASURE_1
95% Confidence Interval for
Difference b

Mean Difference
(J) time

1

2

1.179

.915

.616

-1.113

3.472

3

3.128 *

.869

.003

.952

5.304

1

-1.179

.915

.616

-3.472

1.113

3

1.949

.936

.132

-.395

4.293

1

-3.128 *

.869

.003

-5.304

-.952

2

-1.949

.936

.132

-4.293

.395

2

3

(I-J)

Std. Error

Sig.b

(I) time

Based on estimated marginal means
*. The mean difference is significant at the .05 level.
b. Adjustment for multiple comparisons: Bonferroni.

Lower Bound

Upper Bound
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The PHQ-9 data satisfied Box’s Test (p= .712) and Levene’s Test (p values =
.198 for TP1, .377 for TP2 and .260 for TP3) but failed the assumption of Sphericity (p<
.009). (Table 5).

Table 5.
Mauchley’s test for Sphericity on PHQ-9 data indicating failure of the assumption.
Mauchly's Test of Sphericitya
Measure: MEASURE_1
Epsilon b
Within Subjects
Effect
time

Mauchly's

Approx.

W

Chi-Square

.773

9.521

df

Sig.
2

Greenhouse-

Huynh-

Lower-

Geisser

Feldt

bound

.009

.815

.847

.500

Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent
variables is proportional to an identity matrix.
a. Design: Intercept
Within Subjects Design: time
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests
are displayed in the Tests of Within-Subjects Effects table.

A Greenhouse-Geisser correction identified a value of p< .061 for time and p<
.184 for the time*gender interaction (Table 6). This lack of significance indicates no
within-subjects effects. Further testing found no within-subjects or main effects for
discipline or modality. However, a Test of Between-Subjects found a significant effect
between genders (F(4.425, partial eta squared= .109; p< .042) (Table 7) further evidenced
in the Estimated Marginal Means of Gender*time (Table 8).
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Table 6.
Greenhouse-Geisser correction for Sphericity.

Table 7.
Test of Between-Subjects Effects on the PHQ-9 data showing significant effect between
genders.
Tests of Between-Subjects Effects
Measure: MEASURE_1
Transformed Variable: Average
Type III Sum of
Source
Intercept
Pt_Gen
Error

Squares

Partial Eta
df

Mean Square

F

Sig.

Squared

16840.909

1

16840.909

214.696

.000

.856

347.085

1

347.085

4.425

.042

.109

2823.871

36

78.441
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Table 8.
Estimated Marginal Means of gender over time

To further explore the difference, the dataset was split between genders. Using
univariate repeated measures for gender, differences were found within the genders, as
well. Female scores made a steady decline resulting in a statistically significant reduction
(p< .041, CI .130 to 7.415) overall (Table 9) and had a steeper, although not significant,
reduction within the intervention period. Male scores had a more rapid decline in the first
time period but rebounded in the second time period to have a statistically insignificant
result overall. (Figure 2.).

Table 9.
Pairwise comparison of PHQ-9 scores for Female Gender over the 3 time points.
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Figure 2. Graphed means of male (1.0) and female (2.0) scores on the PHQ-9 for all
three timepoints.

Content Analysis of Interview Responses
Thirteen of the fifteen providers (87%) were available and willing to participate in
qualitative interviews following the period of data gathering. Triangulation was managed
with the use of three coders and the anonymity of the interviewees on the transcripts that
were reviewed. The PI worked at maintaining an awareness of the intrusion of any
preconceptions and maintained objective curiosity as to the results to address reflexivity.
Four global themes emerged with 14 organizing themes comprised of 64 distinct codes
with 338 references (Table 11. Frequency distribution). The themes focused on the (a)
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barriers to the use of MBC, (b) MBC utilization and facilitators, (c) the measurementbased care concept, and (d) the operational process of the initiative, itself.

1. Barriers to measurement-based care.

1.1 Burden.
Providers expressed some concerns about the possible burden imposed by the
process on patients and wanted to make sure patients were willing to complete the
forms. Concerns were also expressed about the time burden on providers seeing
clients for medication management encounters. This was identified as being a
problem in extending the use of MBC in their roles outside the Clinic where tight
scheduling often limited visits to 15 minutes with little time for review of results.

If I had someone that came in over the age of 60 or 65, I would usually do what’s
called a MOCA, a Montreal Cognitive Assessment Tool, because that’s great
utility for me to see where they are on a cognitive basis. I use those really often
and you can’t do those in 2 minutes.

So I had [different MBC tools] in my desk and I would utilize that. The only
problem was the number of people that they wanted me to see in an hour and that
makes it hard to cover that type of material in a 15-minute visit.

“There is definitely a certain labor cost to having more forms to fill out.”
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1.2 Choice of Appropriate Tool.
With the variety of measurement-based tools available in Psychiatry, some
providers questioned the use of the PHQ-9 and the GAD-7.

“I know the PHQ-9 is the kind of standard but I don’t particularly like that tool. I
think it’s great for use with primary care but I don’t think it’s good in Psychiatry.”

“Now when the government got involved in, initially, the meaningful use kind of
stuff, the big tool was the PHQ-9 and I’m like, it’s not meaning a whole lot to
me.”

Other issues raised were over the accuracy of a self-reported tool versus one that the
provider completed based on clinical observation.

1.3 Patient Population and Diagnosis.
Some providers raised the issue of the risk of patient abuse of the tool and its
scoring for secondary gain. In line with this were statements regarding the emotional
lability of patients with personality disorders whose scores could vary widely within
the span of one day bringing into question the reliability and validity of the score. The
underlying message was that MBC might not be appropriate for all patients and
diagnoses.
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“I’d have to be more careful using it in those patients because I think you can get a
false reading.”
1.4 Concern for Use/Depersonalizing Care.
Some cautioned that too much emphasis on MBC ran the risk of ‘treating to the
score’ rather than treating the patient. Some felt that the score didn’t change the
interventions and that they didn’t require a tool to tell them what the patient was
already stating.

“I’m an old therapist so there’s times when I trust my gut better.”

“Like I said, if they were miserable, they would have told me.”

2. The value of measurement-based care.

2.1 Baseline measurements and markers.
Many providers found the scores were particularly helpful in the beginning of
treatment. Establishing a baseline measurement gave them a starting point from
which to work and helped develop an understanding of a person that they did not
know.

“With this newer guy, he was a little harder to read and so that helped me kind of
cue in.”
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I think the most utility I’ve ever had with utilizing questionnaires and those types
of tools has been upon the initial eval of a patient because I can see where they
are from the beginning.

This is something we need to utilize in certain aspects. Especially if you’re having
a lot of problems with getting patients to really talk with you. Sometimes they’re
more willing to sit down with a piece of paper than they are to do some face to
face at times. It’s hard for them to verbalize exactly what they are experiencing.

The scores were a way to keep track of symptoms and offer an alert for sudden
changes.

I was surprised at how depressed and anxious my patients were because they
didn’t tell me that. Obviously, when they were given a structured questionnaire
that was self-reported there was a difference between… I’m surprised. Yeah.

“It’s quantifying. Saying the anxiety is trending up or down or the depression is
trending up or down.”

“I looked at the scores and noticed if there was a pattern.”

“It’s a good standard marker for your interventions and is helpful to show
outcomes.”
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2.2 Guides treatment.
The scores were used as a barometer of treatment efficacy and an indicator of
progress. Some providers found it helped focus treatment, using the individual tool
questions rather than the global score, as a point for discussion. Others found the lack
of change in score results as justification for more aggressive or off-label treatment
interventions.

“I have changed the modality I use based on the patient’s scores.”

So if I see the score was a little bit higher than the previous score, I kind of like
ask the patient what happened the week prior? What changed? How come? So it
caused me to zero in on what is happening to increase the score now.

For the folks who tended to have more persistently high scores, I was more ready
to go toward more adjunctive treatments. Things that may not have been first line
or even officially FDA approved but had some evidence in the scientific
literature. Having that number in my hand gave me more confidence to try
something a bit more experimental.

2.3 Use as an adjunct.
Most described MBC’s value as that of an adjunct to their clinical judgment. It
served as an extra datapoint against which to measure their perceptions – looking for
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congruence between the scores and what they were seeing and experiencing with the
client. One resident reported that the validation of their perceptions by the scores
increased their clinical confidence. A number believed that MBC was more useful
with pharmacotherapy rather than psychotherapy.

“It’s super useful as a tool. They say medicine is an art and a science. You need a
carpenter and a hammer.”

“There’s some limitations just like anything else that’s a tool. Like anything, if
used appropriately, it’s very useful.”

“It’s another piece of data that you use in conjunction with your clinical
judgment.”

So I already had an idea of how she was doing but the PHQ-9 and GAD-7 gave
another measurement that was validating the kind of measurement I had. And it
was interesting that sometimes they were not necessarily the same. It gave more
information in kind of looking at the whole thing from a different perspective,
which I think was nice.

With regards to psychotherapy, I didn’t really find myself relying too much on the
scores to change what I was talking about because really it was kind of what they
brought up here in the moment in the session that tended to be the focus.
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In other clinics, I use these scales myself all the time. Especially when I am doing
medication management and people come in and they’re like, yeah, I’m better,
but then their scores are worse so the medication didn’t change anything. In
measurement-based practice, I have found it to be much easier and I feel better
about it in general.

2.4 Patient-Centered Care.
Statements emerged from providers about their patient’s responses to the
measurements. Some felt they were receiving better care because their provider
wanted to measure their symptoms. Others felt reviewing the change in scores with
patients encouraged patient self-reflection and the identification of progress that they
may not have realized.

In outpatient, you’re seeing the patient every two or three months and they may
not exactly remember how they were a few months ago. This can be sort of a
reminder, saying, hey, you were reporting this many depressive symptoms. You
were this bad when you started and now look where you’ve come to.

I specifically told them I get that information [from the patient-completed
questionnaire] so it gave it a purpose. They were actually interested in it. I think it
made them feel like they were getting better care.
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3.0 The need for measurement-based care.

3.1 Evidence-based.
In general, the providers recognized that MBC was evidence-based and the
literature strongly supports its use. Many already used MBC in their outpatient
practices outside the Clinic. One provider, who primarily does in-patient work in his
main role, said it was not used much in the in-patient setting but he would like to
begin incorporating its use in that area. All were careful to caution scrutiny on the
reliability and validity of the chosen tools but felt that MBC was now a standard of
care.

“I’ve had experience working in more than one place and one company didn’t use
tools at all. That was kind of disheartening for me.”

“For something such as a tried and true standardized form like the GAD-7, I
would find any clinic suspect that didn’t employ that in some way.”

“For something as ubiquitous as the GAD-7, I think it’s invaluable. I wouldn’t
want to do something that had no evidence behind it.”

3.1 Utility.
All providers expressed that MBC had utility in treatment. Whether using the
global score to measure progress or the individual tool questions to jump start
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exploration and develop behavioral activation interventions to address that one item,
all recommended continued use of MBC.

Typically, it’s easier for me to look at the questions and see how they respond….
And what specifically they are having difficulties with regardless of the treatment.
We can address those in particular rather than the global type of thing.

“I looked at the trajectory and how the score changed.”

“There is definite utility.”

4.0 Operational process of the project.

4.1 Office-based mechanism.
None of the providers looked at the scores in the EMR prior to having reports sent.
Providers felt that having the office staff assist in facilitating the completion of the
tools was a time saver as it didn’t encroach on the clinical time and contributed to a good
patient response rate. However, the delay in score reporting was seen as problematic.
At other clinics, I use these scales myself all the time. But I just imagine as soon
as they got to the waiting room there was some on the wall and they knew that,
okay, just take it and fill it. That saves a lot of time.
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I wanted to share that whenever my patient was filling it in, I was usually having
a glance at it before you sent it to us. Especially for medication management, it
makes a huge difference whether you see it then versus two days later.

4.2 EMR Use.
The understanding of the new EMR was problematic, as well. If providers had
difficulty accessing the program, they often wouldn’t use it during the session. Some had
trouble finding the screening section where the scores were located. Additionally, patient
identification on the reports that were sent was a problem as providers were unaware of
the MRN’s of their patients.
“I didn’t know which ones they were because I was seeing 2 people and there
were no names. I wasn’t sure which one it was for.”
“I glanced very briefly at the scores and found myself trying to match up the
numbers with which patient it might refer to.”

I tried to look back in my emails for the scores to see if there was a change. I
wasn’t sure where to find the scores in the EMR. You probably told me and I
don’t remember because I’m only there once a month.
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4.3 Choice of Tools.
Providers would have liked the option to use other tools. There were a number
available in the EMR for use but, as with the category above, many were unaware that
others existed or that they had the option to use them. Some also felt a providercompleted tool would be more accurate.
“I’ve always used either the HAM-D or a Beck [Depression Rating Scale],
specifically for depression because it gave a little more detail.”

“I just worry about the subjectivity of it.”

4.4 Outcome Reporting.
Trended scores were randomly sent to providers in an Excel spreadsheet with
dates of service and the global score on each tool for each date or in a line graph form
generated by the EMR that covered the totality of treatment dates rather than by
individual date. Providers varied in their preferences of reporting. Three (23%) preferred
the Excel spreadsheet and the numbers, three (23%) had no preference and seven (54%)
preferred the graph.
“The graph form is more useful. There’s a better visualization of it.”

39

Figure 3. Code map 1 of qualitative interview data

Figure 4. Code map 2 of qualitative interview data
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Table 10.
Means, standard deviations and frequency distribution of codes within the qualitative
data.

Project Process Results

Following the phases of Lippitt’s theoretical framework, the problem was
diagnosed in May of 2018 and a guideline for the intended change developed shortly
thereafter once approval was received from the Board of Directors. There was substantial
support and motivation for change on the part of the Executive Director. Driving forces
included the need to determine the Clinic’s effectiveness for grant submissions by the
Chief Development Officer. Restraining forces focused around the integration of the new

41

electronic health record. There was resistance from the first Clinic manager at the time
for anything computer-related and she would occasionally forget to give clients the
questionnaires. Some of the providers had never used an EMR and struggled with its use
requiring more than one education session by the PI for training. Every provider had
difficulty remembering user-id’s and passwords and needed the PI, as superuser, to re-set
their accounts so they could gain access to the program. The PI was actively involved in
the entire process as the primary change agent serving as computer superuser, educator,
troubleshooter for office functions, and data manager.

Instituting the use of the EMR in October allowed most of the initial problems to
be corrected by January of 2019. This was assisted by the hire of a new office manager in
late December, 2018 who was comfortable with the EMR and set up an organized
process for distributing the questionnaires. Data missing from the early months created
some difficulties with the ANOVA as SPSS would only include cases where all three
timepoints had numbers. All cycles went according to plan with minor corrections made
to address the issues using the PDSA framework. By March of 2019, the questionnaire
procedure had become systematized by both the clients and office manager resulting in a
100% completion rate. In May of 2019, the PI began to turn over some of the superuser
functions to the office manager as part of the termination process of the helping
relationship in Lippitt’s phase 7. Additionally, using feedback from the qualitative
interviews, the plan was made to change the process after completion of the project
whereby clients brought their completed questionnaires into their session to be reviewed
and signed off by the provider. The forms were returned to the office manager at check
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out and the office manager would add the scores into the EMR. The results of the project
with a statistical report on the scores and Clinic effectiveness was provided to the Board
of Directors at the September, 2019 Board meeting.

Discussion
Measurement-based care has been recognized as evidence-based practice and an
important aspect of care in current day healthcare and reimbursement. The primary
problem, and one of the aims of this project, has been in accomplishing successful and
consistent use of this practice. Few studies have focused on implementation strategies
and tailoring the implementation to the context and setting. This project allowed for this
from the start with (a) approval from a Non-Profit Board of Directors, (b)
operationalization of a new EMR, (c) the embedding of measurement tools, (d) the
establishment of an office-based process to engage clients and ensure completion and
return of scores, and (d) a mechanism to bring those scores into the awareness of the
provider. Working with theoretical frameworks in a cyclic fashion kept the project on
track with the element of time contributing to the processes becoming a routine aspect of
daily workflow.
The success of the project in meeting its goal and first objective (100% patient
response rate) was largely due to the support of the Board and the engagement of the
second office manager in generating patient acceptance of the process. As Jensen-Doss,
et al. (2018) found, organizational factors such as the provision of resources and the drive
to meet funder requirements are key determinants in the adoption of MBC by providers in
these types of settings where they might not use MBC elsewhere.
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The second objective was to compare client score changes over time to ascertain
positive movement toward stabilization. For both depression and anxiety, the providers
were successful- regardless of modality or discipline- in reducing distressing symptoms
over the 7-month course of the project. These outcomes were important metrics for the
Clinic’s effectiveness reporting. Of note in the PHQ-9, when separated, females started
with higher score than males, indicating more symptom acuity. They were slower to
respond but made a steady decline to a statistically significant end score. They also had a
somewhat steeper decline during the intervention period where scores were proactively
reported to providers. While the steeper trajectory was not significant here, a larger ‘N’
might have impacted this result. Males, on the other hand, responded rapidly with
symptom reduction but rebounded later in their care to near baseline levels. The
significant result on the aggregated PHQ-9 scores were apparently driven primarily by
the female clients. This unexpected finding warrants further investigation to understand
what drives differences in treatment response based on gender.
The intervention had a particularly strong effect on the symptoms of anxiety. One
possibility for this is that depression and anxiety symptoms are frequently interwoven.
Many patients attribute the symptom cluster to depression and don’t separate the
symptoms as distinct disorders. Once the providers saw the scores and realized that
anxiety was a separate component of the client’s presentation, they could more actively
address it. Overall, awareness of the scores had an impact on treatment.
An exploration of provider attitudes found many consistencies with the current
literature but differences of opinion between the providers existed, as well. A circular
paradigm seemed to be at play. Some didn’t trust the results of the patient-scored tool
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because it was “too subjective” on the patient’s part. Others felt they didn’t need a tool at
all, trusting and preferring the subjective responses of what the patient would tell them.
Others found that patients were unable to tell them and needed the tool to identify their
concerns, coming full circle to where they would need to trust those subjective responses.
Most did find value and utility in MBC although the value varied with the type of client
and the tool. Finding the right fit was important as was maintaining control over the
choice of tool.
Measurement-based care has been in the literature with increasing frequency over
the last decade and, following the recommendation of Harding, Rush and Arbuckle
(2011), is now included in residency trainings as an evidence-based practice. Possibly for
this reason, the residents were more open to the use of these tools and were more likely to
utilize the scores to guide treatment decisions than their older counterparts. Most did
feel, however, that MBC was best used in outpatient settings with pharmacotherapy
where they had a longer timeframe to work with a client and watch for specific changes
such as in sleep or appetite. All agreed that lack of time was the predominant detractor to
the use of MBC, even when they really wanted to use it, so an office resource to assist in
obtaining the scores made a great difference. They were unanimous in their
recommendation to continue the process as long as they could see the scores at the time
the patient completed the questionnaires.
Given the limitations identified by the providers related to variation in tools,
patient response, and context, all agreed that the tools were just that – tools and an
adjunct assisting the skilled ‘carpenter’ in the work. While they are no replacement for
experience, knowledge and expertise, they can make the work faster, easier and more
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precise – and thus, more efficient leading to cost effectiveness. In this era of managing
population health, and the emphasis on meeting the 6 aims of the IOM (2001), MBC can
make a strong contribution to the process.
Limitations
There were strengths and limitations within the project. A strength was that the
Clinic was small with a consistent and dedicated group of providers willing to participate
in this project. In addition, because of the small size, there was only one office staff
person to educate on the new workflow. This allowed a degree of control over the
initiation of the processes that might not exist with a larger office setting. With the
addition of more office assistants, and with any staff turnover, there would need to be ongoing training with the risk of gaps in consistency.
While the strength was its small size, it was also its greatest disadvantage as it
impacts the generalizability of the findings. The major limitation to the study was the
small sample size. Some of the results appeared to show a trend that, with a larger ‘N,’
might have proven significant. Some clients who began in treatment were lost to attrition
while new clients were added. This resulted in a compressed time period for
measurements to have been taken, thus potentially influencing the data analysis. A yearlong time frame would have yielded stronger results. The time lag between the client
completing the questionnaire and the provider receiving the score was problematic for
those providers and patients who only came to the Clinic once per month or less. The
provider was seeing scores that were a month old, inaccurately reflecting the patient’s
current status. The maintenance workflow is designed to correct this issue such that
providers see the scores immediately and can act on current data.
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For the qualitative portion of the study, it would have been preferable to wait until
the quantitative results had been analyzed before generating the semi-structured
questions. Questions could have been added to explore the findings related to anxiety
and gender but would have required a resubmission to the IRB, taking additional time.
The residents, having completed their rotation, would have moved on and been
unavailable for interviews so the decision was made to remain with the original approved
questions.
Implications for Practice
The use of the research and PDSA models where outcomes of a work process are
regularly analyzed for response and adjusted accordingly based on those results is an
important practice in determining efficacy. MBC assists with that by offering objective
points for comparison measurement. The results showed the use of the measurement tools
worked to engage the patient in a review of their own care and, as some of the providers
found, afforded a very different view from how the providers thought they were
progressing ultimately leading to changes in treatment and positive patient outcomes.
The key was in the active use of it by clinicians.
When attempting to embed MBC into treatment, a team collaboration can work
the best with the team comprised of providers, office staff and patients engaged in their
own care. Providers can and should choose their tools of choice based on the clients that
they see. Office staff can manage the distribution and collection of tools, making it part
of the routine check-in/check-out process, and later document scores in the EMR. Clients
are educated to come prepared to be self-reflective in answering questions on their mood
and its effects on their functional status and abilities.
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If the active use of MBC is made difficult by time constraints, integration of its
most timebound aspects into waiting room time and office staff workflow can facilitate
its application. Even in the absence of an office assistant, as one provider noted, having
the questionnaires in a wall bracket for patients to complete on arrival would work. The
plan to have clients bring the questionnaire in to their clinician for review and sign-off
ensures awareness of scores in real time, making them more actionable, and the process
more likely to be sustained. Scores can then be placed in the EMR for report management
and trending.
The study project is worth replicating for several reasons. Use with a larger
sample and over a longer period of time might make the significance of the intervention
more pronounced – especially with depression in females where the intervention had a
trending effect. A broader grouping and number of disciplines might show how
differences in their respective academic trainings on the use of MBC affects its continued
implementation. This can inform academic areas as to its inclusion in curricula. MBC can
also be used to further explore the gender difference in treatment response found in the
data analysis.
Conclusion
This project was an initiative to institute MBC in a Clinic where it had not
previously existed, remove barriers to use and, ultimately, to encourage and facilitate full
adoption of its application into the practice. Measurement based care can assist with
treatment and provide outcome data but only if it is actually viewed and used to drive
changes in care. This study showed that providers don’t actively seek out this information
in the chart but being exposed to the scores affected their behavior and approaches to
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treatment. Working in cycles with adjustments made along the way to overcome barriers
was effective in incorporating the process into the normal, accepted workflow of the
Clinic and decreased resistance to the change. The combination of quantitative measures
showing a significant reduction in patient anxiety symptoms once providers were made
aware of scores, and the qualitative data showing some of the highest frequency of
comments related to the use of MBC as a barometer of treatment efficacy and its value in
guiding treatment, make MBC worth continuing even in psychiatric practices not
governed by the Joint Commission standards.
The success of the implementation of MBC in this Clinic shows that even small,
non-profits can incorporate MBC into their practices with a minor adjustment in their
workflows and a collaborative, team approach. Ultimately, the Clinic will benefit from a
quantification of clinical outcomes for incorporation into grant requests or insurance
submissions. Providers will see the objective outcomes resulting from their work. And
changes in treatment course, based on symptom feedback, will benefit patient care and
their overall clinical success- all meeting the goals of the IOM.
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Appendix III
Consent to Participate in Research
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Deirdre Rea, MSN, RN from
James Madison University. The purpose of this study is to implement evidence-based care into
clinical practice at Mental Health America of the Roanoke Valley (MHARV) and explore factors
associated with the use of measurement based care by providers. This study will contribute to
the researcher’s completion of her Doctor of Nursing Practice final project.

Research Procedures
Should you decide to participate in this research study, you will be asked to sign this consent
form once all your questions have been answered to your satisfaction. This study consists of an
interview that will be administered to individual participants at MHARV. You will be asked to
provide answers to a series of questions related to your thoughts and perceptions regarding
measurement- based care. The interview will be recorded for accurate understanding of your
statements.

Time Required
Participation in this study will require approximately 20-30 minutes of your time.

Risks
The investigator does not perceive more than minimal risks from your involvement in
this study (that is, no risks beyond the risks associated with everyday life).
Benefits
Potential benefits from participation in this study include an understanding of any barriers to
the use of measurement-based care by providers and whether frequent use affects adoption of
the practice.

Confidentiality
The results of this research may be presented at poster/podium presentations. The results of
this project will be coded in such a way that the respondent’s identity will not be attached to the
final form of this study. The researcher retains the right to use and publish non-identifiable
data. While individual responses are confidential, aggregate data will be presented representing
averages or generalizations about the responses as a whole. All data will be stored in a secure
location accessible only to the researcher. Upon completion of the study, all information that
matches up individual respondents with their answers including audio recordings will be
destroyed.
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Conflicts of Interest
The researcher is a member of the Board of Directors of Mental Health Ame rica of the Roanoke
Valley but is engaging in this study only as a student of James Madison University. The Board of
Directors of MHARV met in private session to discuss the study and make a determination on
any concerns for conflict of interest on the part of the researcher. The study was found to be in
line with the goals of the clinic and the Strategic Plan of the agency so no conflict of interest was
found and permission was granted.

Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you
choose to participate, you can withdraw at any time without consequences of any kind.

Questions about the Study
If you have questions or concerns during the time of your participation in this study, or after its
completion or you would like to receive a copy of the final aggregate results of this study, please
contact:
Researcher’s Name: Deirdre Rea

Advisor’s Name: Jeannie Garber, DNP

Department: Nursing

Department: Nursing

James Madison University

James Madison University

Email Address: reado@dukes.jmu.edu

Email Address: garbe2js@jmu.edu

Telephone: (540) 355-6478…

Questions About Your Rights as a Research Subject
Dr. Taimi Castle
Chair, Institutional Review Board
James Madison University
(540) 568-5929
castletl@jmu.edu
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Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in
this study. I freely consent to participate. I have been given satisfactory answers to my
questions. The investigator provided me with a copy of this form. I certify that I am at least 18
years of age.

I give consent to be audio recorded during my interview. ________ (initials)

______________________________________
Name of Participant (Printed)

______________________________________ ______________
Name of Participant (Signed)

Date

______________________________________ ______________
Name of Researcher (Signed)

Date
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